Naftopidil (KT-611) is a selective ?1-adrenergic receptor antagonist with Ki of 3.7 nM, 20 nM, and 1.2 nM for ?1a, ?1b, and ?1d, respectively, used for the treatment of benign prostatic hyperplasia. *For Research & Development use only. Product is not intended for drug, household, or human consumption.